1 Min Read
BRUSSELS, June 26 (Reuters) - Gimv NV : * Invests in biopharmaceutical company Complix * Complix investment is part of a total series B equity financing round of
12 million eur
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.